Clinical-Grade Human Neural Stem Cells Promote Reparative Neovascularization in Mouse Models of Hindlimb Ischemia
Author(s) -
Rajesh Katare,
Paul Stroemer,
Caroline Hicks,
Lara Stevanato,
Sara Patel,
Randolph Corteling,
Erik Miljan,
Indira Vishnubhatla,
John D. Sinden,
Paolo Madeddu
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.113.302592
Subject(s) - hindlimb , ischemia , medicine , neovascularization , angiogenesis , blood flow , neurogenesis , perfusion , infarction , neural stem cell , anesthesia , pathology , stem cell , biology , neuroscience , myocardial infarction , genetics
CTX0E03 (CTX) is a clinical-grade human neural stem cell (hNSC) line that promotes angiogenesis and neurogenesis in a preclinical model of stroke and is now under clinical development for stroke disability. We evaluated the therapeutic activity of intramuscular CTX hNSC implantation in murine models of hindlimb ischemia for potential translation to clinical studies in critical limb ischemia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom